Datametrex Secures Approximately $650,000 Purchase Orders
Rhea-AI Summary
Datametrex (OTC:DTMXF) announced on November 27, 2025 that its subsidiary Datametrex Korea secured purchase orders totaling approximately CAD $650,000. The P.O.s represent roughly CAD $650,000 in new revenue with an approximate 20% gross profit margin. The company described the orders as part of its land and expand strategy and said they reinforce its role as an IT infrastructure solutions provider to major global partners.
The announcement highlights contribution from Korean operations and management commentary emphasizing continued partnership-driven growth and operational execution.
Positive
- Purchase orders totalling CAD $650,000
- Work provides CAD $650,000 in new revenue
- Orders secured via Datametrex Korea, expanding international presence
Negative
- Reported ~20% gross profit margin, limiting near-term profitability impact
Key Figures
Market Reality Check
Peers on Argus
Before this news, DTMXF was down 1.16% while peers were mixed: HWNI down 2.33%, NOSUF and CISCF flat, but GTLL and GTCH sharply higher at 100% and 50%, suggesting stock-specific rather than broad sector trading.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 01 | Clinic services expansion | Positive | -1.2% | Walk-in services launch at Calgary and Edmonton Imagine Health clinics. |
| Nov 24 | Staffing expansion | Positive | -1.7% | New physicians added at Calgary and Edmonton clinics to boost capacity. |
| Nov 21 | Clinic relocation | Positive | -14.2% | Reopening of Edmonton South clinic in a new location for Imagine Health. |
| Nov 20 | Clinic relocation | Positive | +42.9% | Calgary Imagine Health clinic relocation to Capitol Hill, fully operational. |
| Nov 14 | Equity financings | Neutral | +12.2% | Common share and subscription receipt financings to fund Yuzu acquisition plans. |
Recent operational expansion updates often coincided with negative next-day moves, while one clinic relocation and the November financings saw positive reactions, indicating mixed but frequently contrarian trading around company news.
Over the last few weeks, Datametrex reported multiple clinic expansions and relocations through Imagine Health, plus financings totaling $5,133,500 on Nov 14, 2025. Three clinic-related updates on Nov 21, Nov 24, and Dec 1 saw negative reactions, while the Nov 20 Calgary relocation and the financings drew positive moves. Today’s new purchase orders add IT infrastructure revenue growth alongside ongoing healthcare expansion and recent capital raising.
Market Pulse Summary
This announcement highlights new purchase orders totaling about CAD $650,000, with an indicated gross margin near 20%, reinforcing Datametrex Korea’s role in IT infrastructure solutions. Set against recent clinic expansions and relocations plus financings of $5,133,500, it adds another incremental growth data point. Investors may watch how future orders, clinic performance, and execution of the Yuzu payment initiative evolve alongside the company’s trading pattern around operational news.
AI-generated analysis. Not financial advice.
TORONTO, ONTARIO / ACCESS Newswire / November 27, 2025 / Datametrex AI Limited (the "Company" or "Datametrex") (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce that it has received Purchase Orders ("P.O.s") with a combined value of approximately CAD
In total, the P.O.s represent approximately CAD
Paul Haber, CEO of Datametrex, commented, "These purchase orders from our long-standing partnerships with global enterprises represent important milestones for our organization. They demonstrate the continued confidence that major corporations place in our technology capabilities and highlight our team's commitment to delivering advanced, reliable IT infrastructure solutions. We are proud of our Korean operations for consistently driving growth and strengthening our presence in key international markets."
About Datametrex
Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company specializes in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.
For more on Datametrex, please visit our website at www.datametrex.com.
For Additional Information
Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
info@datametrex.com
(416) 318-6501
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.
Forward-Looking Statements
This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to healthcare business and other Company plans.
While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.
Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis and available on the Company's profile at www.sedarplus.ca.
This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.
###
SOURCE: DataMetrex AI Ltd.
View the original press release on ACCESS Newswire
FAQ
What did Datametrex (DTMXF) announce on November 27, 2025?
How much new revenue do the Datametrex (DTMXF) purchase orders represent?
What gross profit margin did Datametrex (DTMXF) report for the new orders?
Which Datametrex subsidiary secured the purchase orders mentioned by DTMXF?
What strategic significance did Datametrex (DTMXF) attribute to the CAD $650,000 orders?
